ALLIANCEBERNSTEIN L.P. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$27,000
-3.6%
12,4000.0%0.00%
Q4 2020$28,000
-24.3%
12,400
-11.4%
0.00%
Q3 2020$37,000
-24.5%
14,000
-11.9%
0.00%
Q2 2020$49,000
+600.0%
15,900
+695.0%
0.00%
Q1 2015$7,000
-12.5%
2,000
-9.1%
0.00%
Q4 2014$8,000
-60.0%
2,200
-45.0%
0.00%
Q3 2014$20,000
-63.6%
4,0000.0%0.00%
Q2 2014$55,000
+816.7%
4,000
+868.5%
0.00%
Q1 2014$6,000
+200.0%
413
+93.9%
0.00%
Q4 2013$2,0000.0%2130.0%0.00%
Q3 2013$2,0002130.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders